
ngs of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update so
commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 r
当前文章:http://j11ti4.zentaike.cn/u45v/hxttr.html
发布时间:02:56:25